HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Underwood named Olay ambassador

This article was originally published in The Rose Sheet

Executive Summary

Procter & Gamble skin-care brand has named country crooner Carrie Underwood as its first-ever North American celebrity ambassador. "We are thrilled that someone as inspirational as Carrie has joined Olay," Joe Arcuri, vice president for North America, P&G Beauty, says in a Sept. 9 release. "Carrie epitomizes Olay's mission to challenge possibilities and encourage a new generation of women to learn about skin care and make a noticeable impact on their skin's appearance." Underwood has fond childhood memories of her mother using Olay Beauty Fluid and encouraging her and her sisters to take care of their skin. "I love that Olay has managed to change with the times, yet stay in touch with women of all ages who want affordable 1skin-care products that do what they promise," Underwood says. Olay is sponsoring Underwood's "Play On Tour" this fall with shows in cities throughout the U.S. and Canada from September to December 2010

You may also be interested in...



Rising Costs, Price Pressure Usher In Uncertain Year Of The Rat In China

Once the world's factory, China has seen costs inch up while drug prices are being cut deeply by centralized procurement schemes. As uncertainties mount, companies need to focus on improving process and scale-up technology, suggested industry observers at a JPM panel discussion on innovation and market access challenges.

Biocon-Mylan's Plans For Broader US Fulphila Access, Glargine On Track

Biocon-Mylan press ahead with plans to broaden patient access in the US to biosimilar pegfilgrastim and are enthused with the initial uptake for their trastuzumab biosimilar ahead of more upcoming competition. A mid-2020 US launch for partnered insulin glargine is also on course.

JT Gains World-First Topical JAK Inhibitor Approval

Latest new drug approvals in Japan include the first anywhere for a topical JAK inhibitor and also a marketing clearance for a new contender in the large prostate cancer space.
UsernamePublicRestriction

Register

RS017192

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel